C Diff Vaccine Shows Lot Consistency, Induces Toxin A and B Antibody Responses

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.

Related Keywords

Shane Christensen ,J Lewis Research ,Foothill Family Clinic ,Ccdi ,C Diff ,Clostridioides Difficile ,Vaccine ,Antibody Response ,Toxin A ,Toxin B ,Immunogenicity ,Consistency ,